Advertisement

Pharmaceutical Chemistry Journal

, Volume 29, Issue 2, pp 96–99 | Cite as

Synthesis and antitumor properties of 13-dihydro-14-hydroxycarminomycin

  • L. S. Povarov
  • E. N. Bychkova
  • V. E. Tarasova
  • L. A. Ul'yanova
  • N. G. Shepelevtseva
  • N. P. Potapova
Search for New Drugs
  • 31 Downloads

Abstract

Reduction of the carbonyl group C(13) in 14-hydroxycarminomycin by the action of potassium borohydride yielded 13-dihydro-14-hydroxycarminomycin. Its antitumor activity was studied in comparison with carminomycin and doxorubicin for four tumors grafted to mice, namely, lymphadenosis HK/Li, ascitic Ehrlich carcinoma, hemocytoblastosis La, and leucemia P-388. The new compound was shown to have a high antitumor activity and a broad spectrum of antitumor action which is more pronounced than that of carminomycin and doxorubicin, while with respect to hemocytoblastosis La it is equal to the latter. Its effect on leukemia P-388 is lower than that of carminomycin. The drug exhibits considerable selectivity in its antitumor effect with respect to lymphadenosis HK/Li, exceeding the selectivity of doxorubicin and carminomycin. The selectivity of the antitumor effect of the drug with respect to Ehrlich carcinoma is virtually the same as that of carminomycin, but lower than that of doxorubicin.

Keywords

Carcinoma Potassium Leukemia Organic Chemistry Carbonyl 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    N. N. Blokhin and N. I. Perevodchikova.Chemotherapy of Tumor Diseases [in Russian], Moscow (1984).Google Scholar
  2. 2.
    L. S. Povarov, V. S. Bazhanov, and V. F. Vasekina,Antibiotiki, No. 8, 693 - 695 (1977).Google Scholar
  3. 3.
    L. S. Povarov,Usp. Biol. Khim.,22, 225 - 244 (1982).Google Scholar
  4. 4.
    L. S. Povarov, N. N. Isaeva, L. M. Rubasheva, and E. N. Olsufeva,Zh. Org. Khimii,15, 1560 - 1561 (1979).Google Scholar
  5. 5.
    M. G. Brazhnikova and L. S. Povarov, in:Anthracyclines in Cancer Chemotherapy: Symposium on Doxorubicin and Related Drugs in Anti-Cancer Chemotherapy, Moscow (1981). pp. 42–50.Google Scholar
  6. 6.
    M. G. Brazhnikova, V. B. Zbarsky, V. I. Ponomarenko, and N. P. Potarova,J. Antibiot.,27 (4), 254 - 259 (1974).PubMedGoogle Scholar
  7. 7.
    A. N. Kudrin and G. T. Ponomareva,The Use of Mathematics in Experimental and Clinical Medicine [in Russian], Moscow (1967).Google Scholar

Copyright information

© Plenum Publishing Corporation 1995

Authors and Affiliations

  • L. S. Povarov
    • 1
  • E. N. Bychkova
    • 1
  • V. E. Tarasova
    • 1
  • L. A. Ul'yanova
    • 1
  • N. G. Shepelevtseva
    • 1
  • N. P. Potapova
    • 1
  1. 1.Research Institute for Finding New AntibioticsRussian Academy of Medical SciencesMoscowRussia

Personalised recommendations